According to the report, the intragastric balloons market was valued at $32.2 million in 2023, and is estimated to reach $115.3 million by 2033, growing at a CAGR of 13.6% from 2024 to 2033.
Request Sample of the Report on – https://www.alliedmarketresearch.com/request-sample/4122
Rise in obesity rates, preference for non-surgical options, and increase in awareness and acceptance are the major factors that drive the growth of the intragastric balloons market. However, limited reimbursement policies and safety concerns hinder the market growth. Moreover, technological advancements and untapped markets in developing economies offer remunerative opportunities for the expansion of the global intragastric balloons market.
Intragastric balloons are non-surgical devices designed to assist with weight loss by occupying space in the stomach for inducing a feeling of fullness and reducing food intake. These balloons are inserted into the stomach endoscopically and filled with saline or gas to occupy a portion of the stomach, limiting its capacity for food intake. This approach helps individuals adhere to reduced-calorie diets and adopt healthier eating habits, facilitating weight loss. Intragastric balloons are particularly beneficial for individuals struggling with obesity who may not qualify for or wish to avoid surgical interventions such as gastric bypass or sleeve gastrectomy, offering a less invasive alternative with potential for significant weight loss and improved metabolic health.
Segment Highlights
By type, the single intragastric balloons segment generated the largest revenue in the intragastric balloons market in 2023. The single intragastric balloons are often preferred over double or triple balloons due to their simplicity and reduced risk of complications. Single balloons require only one insertion procedure, minimizing patient discomfort and procedural time. Additionally, they may offer easier adjustment and removal processes. While double or triple balloons may provide greater volume for weight loss, the complexity of multiple balloons increases the risk of adverse events such as migration or discomfort, making single balloons a preferred choice for many patients and clinicians.
The saline-filled segment to maintain its leadership status during the forecast period
By filling material, the saline-filled segment generated the largest revenue in the intragastric balloons market in 2023, owing to its advantages over gas-filled balloons. Saline-filled balloons offer greater adjustability, providing more precise volume control and customization for individual patient needs. They also pose a lower risk of deflation and migration, enhancing safety and efficacy in weight loss management.
The hospital segment to maintain its leadership status during the forecast period
By end user, the hospital segment generated the largest revenue in the intragastric balloons market in 2023. Hospitals are the primary users of intragastric balloons due to their advanced medical facilities and expertise in minimally invasive procedures. Hospitals offer comprehensive pre-procedural evaluations, insertion, and post-procedural care, ensuring optimal patient outcomes. Additionally, hospitals have the necessary equipment and personnel to manage potential complications effectively, providing patients with a safe and supportive environment for intragastric balloon placement and monitoring.
For Purchase Related Queries/Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/4122
Key Players
- Obalon Therapeutics
- Apollo Endosurgery Inc.
- Allurion Technologies Inc.
- Spatz Medical
- ReShape Lifesciences
- Lexel Medical
- Endalis
- MEDSIL
- Silimed
Industry News
- In February 2022, an article published in the National Institute of Health, stated that in the studied population, about 57.0% of the patients who preferred minimally invasive treatment made their decision under the influence of the healthcare professionals as they recommended minimally invasive treatment and reported less perceived disadvantages following their treatment.
- In 2020, Allurion Technologies Inc. raised $34 million to facilitate the launch of its swallowable weight loss balloon.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2024?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2033?
- Which region has more opportunities?
Get Customized Reports with your Requirements – https://www.alliedmarketresearch.com/request-for-customization/4122
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
